German Registry for Transcatheter Tricuspid Valve Interventions

Launched by LMU KLINIKUM · Nov 28, 2020

Keywords

ClinConnect Summary

The German Registry for Transcatheter Tricuspid Valve Interventions is a study focusing on patients with severe tricuspid regurgitation, which means that the valve in the heart is not closing properly and blood is leaking backward. This trial aims to observe how well certain treatments work for this condition, particularly those using CE certified products designed to repair the tricuspid valve. The study is currently looking for participants aged between 65 and 74, regardless of gender, who are willing to receive these specific treatments and provide their consent to take part.

Eligible participants will receive care at multiple medical centers and will be closely monitored throughout the study. To join, patients must agree to participate and meet the criteria for the treatments being studied. Those under 18 or who do not wish to take part in the study will not be included. This trial is important because it could help improve treatment options for patients with tricuspid valve issues, ultimately aiming to enhance their quality of life.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Interventional treatment of severe tricuspid regurgitation (isolated or in combination with another interventional treatment) with a CE certified product for tricuspid valve repair
• • Informed consent corresponding to criteria of Good Clinical Practice and the decleration of Helsinki as well as to standards of the local ethic commission.
• Exclusion Criteria:
• • No agreement to participation
• • Age \< 18 years